AbbVie is paying $650 million for a dual-targeting immunotherapy from China’s RemeGen. Elsewhere, Alnylam missed an earnings ...
TerraPower, a Bill Gates-backed nuclear company, announced a deal with Meta to build up to eight small modular reactors in ...
The FDA has issued a second complete response letter to Atara Biotherapeutics for its biologicals license application of ...
Last year, however, the news broke that Invesco is selling its Intelliflo business to the PE firm Carlyle. In the process, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback